Word

MONDORARE

Status

Dead

Status Code

710

Status Date

Friday, March 16, 2018

Serial Number

77672421

Registration Number

4007941

Registration Date

Tuesday, August 9, 2011

Mark Type

4000

Filing Date

Tuesday, February 17, 2009

Published for Opposition

Tuesday, May 24, 2011

Cancellation Date

Friday, March 16, 2018

Trademark Owner History

mondoBIOTECH Laboratories AG - Original Registrant

Classifications

5 Pharmaceutical preparations for the treatment or prophylaxis of infectious diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of immunological diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of autoimmune diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of cardiovascular diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of inflammatory diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of neurodegenerative diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of neurological diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of psychiatric diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of otorhinolaryngologic diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of eye diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of dental diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of kidney diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of liver diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of gastrointestinal diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of metabolic diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of gynecological diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of andrological diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of urologic diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of geriatric diseases and states in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of orthopaedic diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of diseases of the bones and joints in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of muscular diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of skin diseases in humans or animals; pharmaceutical preparations for the treatment or prophylaxis of pain in humans or animals; pharmaceutical preparations for the treatment of and preparation to surgical states in humans or animals; pharmaceutical preparations for anaesthesia in humans or animals; pharmaceutical preparations for obstetrics or abortion in humans or animals; pharmaceutical preparations for cosmetic purposes in humans or animals; Pharmaceutical preparations for treating respiratory diseases and asthma; Pharmaceutical preparations for treatment of pulmonary diseases; Pharmaceutical preparations for the treatment of hypertension; Pharmaceutical preparations for use in the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Biological preparations for medical purposes; Biological preparations for veterinary purposes; Bronchodilating preparations; Veterinary preparations for the treatment of infectious diseases; Veterinary preparations for the treatment of non-infectious diseases; pharmaceutical preparations, namely, contrast agents for radiography, x-ray radiography, computer tomography, magnetic resonance imaging, magnetic resonance tomography, ultrasonography or positron emission tomography; Chemical preparations for medical purposes; Chemical preparations for pharmaceutical purposes; Chemical reagents for medical or veterinary purposes; Chemico-pharmaceutical preparations for the treatment or prophylaxis of infectious diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of immunological diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of autoimmune diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of cardiovascular diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of inflammatory diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of neurodegenerative diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of neurological diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of psychiatric diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of otorhinolaryngologic diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of eye diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of dental diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of kidney diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of liver diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of gastrointestinal diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of metabolic diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of gynecological diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of andrological diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of urologic diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of geriatric diseases and states in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of orthopaedic diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of diseases of the bones and joints in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of muscular diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of skin diseases in humans or animals; Chemico-pharmaceutical preparations for the treatment or prophylaxis of pain in humans or animals; Chemico-pharmaceutical preparations for the treatment of and preparation to surgical states in humans or animals; Chemico-pharmaceutical preparations for anaesthesia in humans or animals; Chemico-pharmaceutical preparations for obstetrics or abortion in humans or animals; Chemico-pharmaceutical preparations for cosmetic purposes in humans or animals; Diagnostic preparations for clinical or medical use; Diagnostic preparations for veterinary use; Dietetic substances adapted for medical use; Disinfectants; Preparations for destroying vermin; Fungicides; Herbicides; Drugs for medical purposes; Medicines for the treatment or prophylaxis of dental diseases and states and dental cosmetic purposes; Medicines for the treatment or prophylaxis of infectious diseases in humans or animals; Medicines for the treatment or prophylaxis of immunological diseases in humans or animals; Medicines for the treatment or prophylaxis of autoimmune diseases in humans or animals; Medicines for the treatment or prophylaxis of cardiovascular diseases in humans or animals; Medicines for the treatment or prophylaxis of inflammatory diseases in humans or animals; Medicines for the treatment or prophylaxis of neurodegenerative diseases in humans or animals; Medicines for the treatment or prophylaxis of neurological diseases in humans or animals; Medicines for the treatment or prophylaxis of psychiatric diseases in humans or animals; Medicines for the treatment or prophylaxis of otorhinolaryngologic diseases in humans or animals; Medicines for the treatment or prophylaxis of eye diseases in humans or animals; Medicines for the treatment or prophylaxis of dental diseases in humans or animals; Medicines for the treatment or prophylaxis of kidney diseases in humans or animals; Medicines for the treatment or prophylaxis of liver diseases in humans or animals; Medicines for the treatment or prophylaxis of gastrointestinal diseases in humans or animals; Medicines for the treatment or prophylaxis of metabolic diseases in humans or animals; Medicines for the treatment or prophylaxis of gynecological diseases in humans or animals; Medicines for the treatment or prophylaxis of andrological diseases in humans or animals; Medicines for the treatment or prophylaxis of urologic diseases in humans or animals; Medicines for the treatment or prophylaxis of geriatric diseases and states in humans or animals; Medicines for the treatment or prophylaxis of orthopaedic diseases in humans or animals; Medicines for the treatment or prophylaxis of diseases of the bones and joints in humans or animals; Medicines for the treatment or prophylaxis of muscular diseases in humans or animals; Medicines for the treatment or prophylaxis of skin diseases in humans or animals; Medicines for the treatment or prophylaxis of pain in humans or animals; Medicines for the treatment of and preparation to surgical states in humans or animals; Medicines for anaesthesia in humans or animals; Medicines for obstetrics or abortion in humans or animals; Medicines for cosmetic purposes in humans or animals; Medical preparations for mouth care; Medical preparations for skin care; Sanitary preparations for medical use

35 Business appraisals; Business consulting services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business information services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business inquiry services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business investigation services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business management and organization services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business management assistance services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business management consultancy services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business organization consultancy services for scientific projects in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Business acquisition and merger consultation in the field of medicine, pharmacy, biology, and chemistry or medicine-technology; Procurement of legal and technical know-how (franchising) in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Procurement of scientific cooperations in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Providing business consulting and management services for the commercialization of scientific projects in the field of medicine, pharmacy, biology, chemistry or medicine-technology

41 Providing of training in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of colloquiums in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of conferences in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of congresses in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of seminars in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of symposiums in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Arranging and conducting of workshops training in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Correspondence courses in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Educational services, namely, providing courses of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology; Organization of exhibitions for cultural or educational purposes; Practical training demonstration in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry and medicine-technology

42 Biological research; Chemical analysis; Chemical Research; Chemistry services, namely, performing commissioned preparations, syntheses, patent search and literature search in the field of chemistry; Cosmetic research; Technical research in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry or medicine-technology; Project studies Technical in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry or medicine-technology; Medical and scientific development and research services in the field of medical, biochemical, pharmaceutical and medicine-technological research; Commissioned research and development work in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry or medicine-technology; Commissioned development of pharmaceutical preparations; Medical and scientific research, namely, conducting and evaluating clinical trials of pharmaceutical preparations for statutory approval; Assessment of scientific projects, namely, evaluating their feasibility, scientific value and costs; Assessment of clinical studies and clinical trials; medical, bacteriological and biochemical laboratory services for diagnosis, analysis, research and drug development in the field of medicine

44 Services of a hospital; Services of medical practitioner; Services of a medical clinic; Pharmacy advice in the field of medicine, pharmacy, pharmacology, biology, biotechnology, chemistry, medicine-technology, health policy, business administration or related legal affairs; Medical assistance services; Nursing services; Medical sample testing services for samples provided by patients, volunteers, persons compelled by law, persons compelled by military institutions, persons compelled by educational institutions or employers to provide body samples for diagnostic purposes, treatment purposes and fitness evaluation

MONDO RARE

Trademark Events

Mar 16, 2018

Cancelled Sec. 8 (6-Yr)

Aug 9, 2011

Registered-Principal Register

May 24, 2011

Official Gazette Publication Confirmation E-Mailed

May 24, 2011

Published For Opposition

Apr 21, 2011

Law Office Publication Review Completed

Apr 19, 2011

Approved For Pub - Principal Register

Apr 19, 2011

Examiner's Amendment Entered

Apr 19, 2011

Notification Of Examiners Amendment E-Mailed

Apr 19, 2011

Examiners Amendment E-Mailed

Apr 19, 2011

Examiners Amendment -Written

Apr 19, 2011

Previous Allowance Count Withdrawn

Apr 15, 2011

Withdrawn From Pub - Og Review Query

Apr 2, 2011

Law Office Publication Review Completed

Apr 1, 2011

Approved For Pub - Principal Register

Mar 11, 2011

Examiner's Amendment Entered

Mar 10, 2011

Notification Of Examiners Amendment E-Mailed

Mar 10, 2011

Examiners Amendment E-Mailed

Mar 10, 2011

Examiners Amendment -Written

Oct 8, 2010

Notification Of Final Refusal Emailed

Oct 8, 2010

Final Refusal E-Mailed

Oct 8, 2010

Final Refusal Written

Sep 17, 2010

Teas/Email Correspondence Entered

Sep 17, 2010

Correspondence Received In Law Office

Sep 17, 2010

Teas Response To Office Action Received

Mar 23, 2010

Notification Of Non-Final Action E-Mailed

Mar 23, 2010

Non-Final Action E-Mailed

Mar 23, 2010

Non-Final Action Written

Feb 26, 2010

Teas/Email Correspondence Entered

Feb 26, 2010

Correspondence Received In Law Office

Feb 26, 2010

Assigned To Lie

Jan 28, 2010

Teas Response To Office Action Received

Sep 17, 2009

Notification Of Non-Final Action E-Mailed

Sep 17, 2009

Non-Final Action E-Mailed

Sep 17, 2009

Non-Final Action Written

Aug 25, 2009

Teas/Email Correspondence Entered

Aug 25, 2009

Correspondence Received In Law Office

Aug 25, 2009

Teas Response To Office Action Received

May 8, 2009

Notification Of Non-Final Action E-Mailed

May 8, 2009

Non-Final Action E-Mailed

May 8, 2009

Non-Final Action Written

May 7, 2009

Assigned To Examiner

Feb 21, 2009

Notice Of Pseudo Mark Mailed

Feb 20, 2009

New Application Office Supplied Data Entered In Tram

Feb 20, 2009

New Application Entered In Tram